Flavin Oxidase-Induced ROS Generation Modulates PKC Biphasic Effect of Resveratrol on Endothelial Cell Survival

Dietary intake of natural antioxidants is thought to impart protection against oxidative-associated cardiovascular diseases. Despite many in vivo studies and clinical trials, this issue has not been conclusively resolved. Resveratrol (RES) is one of the most extensively studied dietary polyphenolic...

Full description

Saved in:
Bibliographic Details
Published inBiomolecules (Basel, Switzerland) Vol. 9; no. 6; p. 209
Main Authors Posadino, Anna Maria, Giordo, Roberta, Cossu, Annalisa, Nasrallah, Gheyath K, Shaito, Abdullah, Abou-Saleh, Haissam, Eid, Ali H, Pintus, Gianfranco
Format Journal Article
LanguageEnglish
Published Switzerland MDPI 30.05.2019
MDPI AG
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Dietary intake of natural antioxidants is thought to impart protection against oxidative-associated cardiovascular diseases. Despite many in vivo studies and clinical trials, this issue has not been conclusively resolved. Resveratrol (RES) is one of the most extensively studied dietary polyphenolic antioxidants. Paradoxically, we have previously demonstrated that high RES concentrations exert a pro-oxidant effect eventually elevating ROS levels leading to cell death. Here, we further elucidate the molecular determinants underpinning RES-induced oxidative cell death. Using human umbilical vein endothelial cells (HUVECs), the effect of increasing concentrations of RES on DNA synthesis and apoptosis was studied. In addition, mRNA and protein levels of cell survival or apoptosis genes, as well as protein kinase C (PKC) activity were determined. While high concentrations of RES reduce PKC activity, inhibit DNA synthesis and induce apoptosis, low RES concentrations elicit an opposite effect. This biphasic concentration-dependent effect (BCDE) of RES on PKC activity is mirrored at the molecular level. Indeed, high RES concentrations upregulate the proapoptotic , while downregulating the antiapoptotic , at both mRNA and protein levels. Similarly, high RES concentrations downregulate the cell cycle progression genes, , ornithine decarboxylase and cyclin D1 protein levels, while low RES concentrations display an increasing trend. The BCDE of RES on PKC activity is abrogated by the ROS scavenger Tempol, indicating that this enzyme acts downstream of the RES-elicited ROS signaling. The RES-induced BCDE on HUVEC cell cycle machinery was also blunted by the flavin inhibitor diphenyleneiodonium (DPI), implicating flavin oxidase-generated ROS as the mechanistic link in the cellular response to different RES concentrations. Finally, PKC inhibition abrogates the BCDE elicited by RES on both cell cycle progression and pro-apoptotic gene expression in HUVECs, mechanistically implicating PKC in the cellular response to different RES concentrations. Our results provide new molecular insight into the impact of RES on endothelial function/dysfunction, further confirming that obtaining an optimal benefit of RES is concentration-dependent. Importantly, the BCDE of RES could explain why other studies failed to establish the cardio-protective effects mediated by natural antioxidants, thus providing a guide for future investigation looking at cardio-protection by natural antioxidants.
AbstractList Dietary intake of natural antioxidants is thought to impart protection against oxidative-associated cardiovascular diseases. Despite many in vivo studies and clinical trials, this issue has not been conclusively resolved. Resveratrol (RES) is one of the most extensively studied dietary polyphenolic antioxidants. Paradoxically, we have previously demonstrated that high RES concentrations exert a pro-oxidant effect eventually elevating ROS levels leading to cell death. Here, we further elucidate the molecular determinants underpinning RES-induced oxidative cell death. Using human umbilical vein endothelial cells (HUVECs), the effect of increasing concentrations of RES on DNA synthesis and apoptosis was studied. In addition, mRNA and protein levels of cell survival or apoptosis genes, as well as protein kinase C (PKC) activity were determined. While high concentrations of RES reduce PKC activity, inhibit DNA synthesis and induce apoptosis, low RES concentrations elicit an opposite effect. This biphasic concentration-dependent effect (BCDE) of RES on PKC activity is mirrored at the molecular level. Indeed, high RES concentrations upregulate the proapoptotic , while downregulating the antiapoptotic , at both mRNA and protein levels. Similarly, high RES concentrations downregulate the cell cycle progression genes, , ornithine decarboxylase and cyclin D1 protein levels, while low RES concentrations display an increasing trend. The BCDE of RES on PKC activity is abrogated by the ROS scavenger Tempol, indicating that this enzyme acts downstream of the RES-elicited ROS signaling. The RES-induced BCDE on HUVEC cell cycle machinery was also blunted by the flavin inhibitor diphenyleneiodonium (DPI), implicating flavin oxidase-generated ROS as the mechanistic link in the cellular response to different RES concentrations. Finally, PKC inhibition abrogates the BCDE elicited by RES on both cell cycle progression and pro-apoptotic gene expression in HUVECs, mechanistically implicating PKC in the cellular response to different RES concentrations. Our results provide new molecular insight into the impact of RES on endothelial function/dysfunction, further confirming that obtaining an optimal benefit of RES is concentration-dependent. Importantly, the BCDE of RES could explain why other studies failed to establish the cardio-protective effects mediated by natural antioxidants, thus providing a guide for future investigation looking at cardio-protection by natural antioxidants.
Background: Dietary intake of natural antioxidants is thought to impart protection against oxidative-associated cardiovascular diseases. Despite many in vivo studies and clinical trials, this issue has not been conclusively resolved. Resveratrol (RES) is one of the most extensively studied dietary polyphenolic antioxidants. Paradoxically, we have previously demonstrated that high RES concentrations exert a pro-oxidant effect eventually elevating ROS levels leading to cell death. Here, we further elucidate the molecular determinants underpinning RES-induced oxidative cell death. Methods: Using human umbilical vein endothelial cells (HUVECs), the effect of increasing concentrations of RES on DNA synthesis and apoptosis was studied. In addition, mRNA and protein levels of cell survival or apoptosis genes, as well as protein kinase C (PKC) activity were determined. Results: While high concentrations of RES reduce PKC activity, inhibit DNA synthesis and induce apoptosis, low RES concentrations elicit an opposite effect. This biphasic concentration-dependent effect (BCDE) of RES on PKC activity is mirrored at the molecular level. Indeed, high RES concentrations upregulate the proapoptotic Bax, while downregulating the antiapoptotic Bcl-2, at both mRNA and protein levels. Similarly, high RES concentrations downregulate the cell cycle progression genes, c-myc, ornithine decarboxylase (ODC) and cyclin D1 protein levels, while low RES concentrations display an increasing trend. The BCDE of RES on PKC activity is abrogated by the ROS scavenger Tempol, indicating that this enzyme acts downstream of the RES-elicited ROS signaling. The RES-induced BCDE on HUVEC cell cycle machinery was also blunted by the flavin inhibitor diphenyleneiodonium (DPI), implicating flavin oxidase-generated ROS as the mechanistic link in the cellular response to different RES concentrations. Finally, PKC inhibition abrogates the BCDE elicited by RES on both cell cycle progression and pro-apoptotic gene expression in HUVECs, mechanistically implicating PKC in the cellular response to different RES concentrations. Conclusions: Our results provide new molecular insight into the impact of RES on endothelial function/dysfunction, further confirming that obtaining an optimal benefit of RES is concentration-dependent. Importantly, the BCDE of RES could explain why other studies failed to establish the cardio-protective effects mediated by natural antioxidants, thus providing a guide for future investigation looking at cardio-protection by natural antioxidants.
Background: Dietary intake of natural antioxidants is thought to impart protection against oxidative-associated cardiovascular diseases. Despite many in vivo studies and clinical trials, this issue has not been conclusively resolved. Resveratrol (RES) is one of the most extensively studied dietary polyphenolic antioxidants. Paradoxically, we have previously demonstrated that high RES concentrations exert a pro-oxidant effect eventually elevating ROS levels leading to cell death. Here, we further elucidate the molecular determinants underpinning RES-induced oxidative cell death. Methods: Using human umbilical vein endothelial cells (HUVECs), the effect of increasing concentrations of RES on DNA synthesis and apoptosis was studied. In addition, mRNA and protein levels of cell survival or apoptosis genes, as well as protein kinase C (PKC) activity were determined. Results: While high concentrations of RES reduce PKC activity, inhibit DNA synthesis and induce apoptosis, low RES concentrations elicit an opposite effect. This biphasic concentration-dependent effect (BCDE) of RES on PKC activity is mirrored at the molecular level. Indeed, high RES concentrations upregulate the proapoptotic Bax , while downregulating the antiapoptotic Bcl-2 , at both mRNA and protein levels. Similarly, high RES concentrations downregulate the cell cycle progression genes, c-myc , ornithine decarboxylase (ODC) and cyclin D1 protein levels, while low RES concentrations display an increasing trend. The BCDE of RES on PKC activity is abrogated by the ROS scavenger Tempol, indicating that this enzyme acts downstream of the RES-elicited ROS signaling. The RES-induced BCDE on HUVEC cell cycle machinery was also blunted by the flavin inhibitor diphenyleneiodonium (DPI), implicating flavin oxidase-generated ROS as the mechanistic link in the cellular response to different RES concentrations. Finally, PKC inhibition abrogates the BCDE elicited by RES on both cell cycle progression and pro-apoptotic gene expression in HUVECs, mechanistically implicating PKC in the cellular response to different RES concentrations. Conclusions: Our results provide new molecular insight into the impact of RES on endothelial function/dysfunction, further confirming that obtaining an optimal benefit of RES is concentration-dependent. Importantly, the BCDE of RES could explain why other studies failed to establish the cardio-protective effects mediated by natural antioxidants, thus providing a guide for future investigation looking at cardio-protection by natural antioxidants.
BACKGROUNDDietary intake of natural antioxidants is thought to impart protection against oxidative-associated cardiovascular diseases. Despite many in vivo studies and clinical trials, this issue has not been conclusively resolved. Resveratrol (RES) is one of the most extensively studied dietary polyphenolic antioxidants. Paradoxically, we have previously demonstrated that high RES concentrations exert a pro-oxidant effect eventually elevating ROS levels leading to cell death. Here, we further elucidate the molecular determinants underpinning RES-induced oxidative cell death. METHODSUsing human umbilical vein endothelial cells (HUVECs), the effect of increasing concentrations of RES on DNA synthesis and apoptosis was studied. In addition, mRNA and protein levels of cell survival or apoptosis genes, as well as protein kinase C (PKC) activity were determined. RESULTSWhile high concentrations of RES reduce PKC activity, inhibit DNA synthesis and induce apoptosis, low RES concentrations elicit an opposite effect. This biphasic concentration-dependent effect (BCDE) of RES on PKC activity is mirrored at the molecular level. Indeed, high RES concentrations upregulate the proapoptotic Bax, while downregulating the antiapoptotic Bcl-2, at both mRNA and protein levels. Similarly, high RES concentrations downregulate the cell cycle progression genes, c-myc, ornithine decarboxylase (ODC) and cyclin D1 protein levels, while low RES concentrations display an increasing trend. The BCDE of RES on PKC activity is abrogated by the ROS scavenger Tempol, indicating that this enzyme acts downstream of the RES-elicited ROS signaling. The RES-induced BCDE on HUVEC cell cycle machinery was also blunted by the flavin inhibitor diphenyleneiodonium (DPI), implicating flavin oxidase-generated ROS as the mechanistic link in the cellular response to different RES concentrations. Finally, PKC inhibition abrogates the BCDE elicited by RES on both cell cycle progression and pro-apoptotic gene expression in HUVECs, mechanistically implicating PKC in the cellular response to different RES concentrations. CONCLUSIONSOur results provide new molecular insight into the impact of RES on endothelial function/dysfunction, further confirming that obtaining an optimal benefit of RES is concentration-dependent. Importantly, the BCDE of RES could explain why other studies failed to establish the cardio-protective effects mediated by natural antioxidants, thus providing a guide for future investigation looking at cardio-protection by natural antioxidants.
Author Pintus, Gianfranco
Posadino, Anna Maria
Cossu, Annalisa
Nasrallah, Gheyath K
Eid, Ali H
Abou-Saleh, Haissam
Shaito, Abdullah
Giordo, Roberta
AuthorAffiliation 2 Biomedical Research Center, Qatar University, Doha P.O. Box 2713, Qatar; roberta.giordo@qu.edu.qa (R.G.); gheyath.nasrallah@qu.edu.qa (G.K.N.)
1 Department of Biomedical Sciences, School of Medicine, University of Sassari, CAP 07100 Sassari, Italy; posadino@uniss.it (A.M.P.); cossuannalisa@libero.it (A.C.)
3 Department of Biomedical Sciences, College of Health Sciences, Qatar University, Doha P.O. Box 2713, Qatar
4 Department of Biological and Chemical Sciences, Faculty of Arts and Sciences, Lebanese International University, 1105 Beirut, Lebanon; Abdallah.shaito@liu.edu.lb
5 Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, Doha P.O. Box 2713, Qatar; hasaleh@qu.edu.qa
6 Department of Pharmacology and Toxicology, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon
AuthorAffiliation_xml – name: 4 Department of Biological and Chemical Sciences, Faculty of Arts and Sciences, Lebanese International University, 1105 Beirut, Lebanon; Abdallah.shaito@liu.edu.lb
– name: 2 Biomedical Research Center, Qatar University, Doha P.O. Box 2713, Qatar; roberta.giordo@qu.edu.qa (R.G.); gheyath.nasrallah@qu.edu.qa (G.K.N.)
– name: 1 Department of Biomedical Sciences, School of Medicine, University of Sassari, CAP 07100 Sassari, Italy; posadino@uniss.it (A.M.P.); cossuannalisa@libero.it (A.C.)
– name: 6 Department of Pharmacology and Toxicology, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon
– name: 3 Department of Biomedical Sciences, College of Health Sciences, Qatar University, Doha P.O. Box 2713, Qatar
– name: 5 Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, Doha P.O. Box 2713, Qatar; hasaleh@qu.edu.qa
Author_xml – sequence: 1
  givenname: Anna Maria
  surname: Posadino
  fullname: Posadino, Anna Maria
  email: posadino@uniss.it
  organization: Department of Biomedical Sciences, School of Medicine, University of Sassari, CAP 07100 Sassari, Italy. posadino@uniss.it
– sequence: 2
  givenname: Roberta
  surname: Giordo
  fullname: Giordo, Roberta
  email: roberta.giordo@qu.edu.qa
  organization: Biomedical Research Center, Qatar University, Doha P.O. Box 2713, Qatar. roberta.giordo@qu.edu.qa
– sequence: 3
  givenname: Annalisa
  surname: Cossu
  fullname: Cossu, Annalisa
  email: cossuannalisa@libero.it
  organization: Department of Biomedical Sciences, School of Medicine, University of Sassari, CAP 07100 Sassari, Italy. cossuannalisa@libero.it
– sequence: 4
  givenname: Gheyath K
  orcidid: 0000-0001-9252-1038
  surname: Nasrallah
  fullname: Nasrallah, Gheyath K
  email: gheyath.nasrallah@qu.edu.qa, gheyath.nasrallah@qu.edu.qa
  organization: Department of Biomedical Sciences, College of Health Sciences, Qatar University, Doha P.O. Box 2713, Qatar. gheyath.nasrallah@qu.edu.qa
– sequence: 5
  givenname: Abdullah
  orcidid: 0000-0003-3524-7962
  surname: Shaito
  fullname: Shaito, Abdullah
  email: Abdallah.shaito@liu.edu.lb
  organization: Department of Biological and Chemical Sciences, Faculty of Arts and Sciences, Lebanese International University, 1105 Beirut, Lebanon. Abdallah.shaito@liu.edu.lb
– sequence: 6
  givenname: Haissam
  orcidid: 0000-0003-3460-1413
  surname: Abou-Saleh
  fullname: Abou-Saleh, Haissam
  email: hasaleh@qu.edu.qa
  organization: Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, Doha P.O. Box 2713, Qatar. hasaleh@qu.edu.qa
– sequence: 7
  givenname: Ali H
  surname: Eid
  fullname: Eid, Ali H
  email: ae81@aub.edu.lb, ae81@aub.edu.lb
  organization: Department of Pharmacology and Toxicology, American University of Beirut, Beirut P.O. Box 11-0236, Lebanon. ae81@aub.edu.lb
– sequence: 8
  givenname: Gianfranco
  orcidid: 0000-0002-3031-7733
  surname: Pintus
  fullname: Pintus, Gianfranco
  email: gpintus@qu.edu.qa, gpintus@qu.edu.qa
  organization: Department of Biomedical Sciences, College of Health Sciences, Qatar University, Doha P.O. Box 2713, Qatar. gpintus@qu.edu.qa
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31151226$$D View this record in MEDLINE/PubMed
BookMark eNpVkV1rFDEUhoNUbF175b3kUpDVfMxkZm4EXbZ1sbLSKngXziQn3ZTsZJvMDPbfd-rWsg2BhOQ5Tw55X5OjLnZIyFvOPkrZsE-tj9uGKSZY84KcCMHruajkn6OD_TE5zfmGTaOeppCvyLHkvORCqBMSzwKMvqPrv95Cxvmqs4NBSy_XV_QcO0zQ-9jRH9EOAXrM9Of3Bf3qdxvI3tClc2h6Gh29xDw-wCkGOvHLzsZ-g8FDoAsMgV4NafQjhDfkpYOQ8fRxnZHfZ8tfi2_zi_X5avHlYm5KLvt5XUgrK1MWjWC1kYVyjgM613JmueNSQYltwVxTcgbSsNYIqOoKBTeVaAHljKz2XhvhRu-S30K60xG8_ncQ07WG1HsTUEMzlVdFCUpWRcuxLa1qVWl5KZVVUx8z8nnv2g3tFq3Brk8Qnkmf33R-o6_jqJUS9WSZBO8fBSneDph7vfXZTN8CHcYhayGkrMuKVWxCP-xRk2LOCd3TM5zph8T1QeIT_e6wsyf2f77yHkMIqb8
CitedBy_id crossref_primary_10_3390_foods10040800
crossref_primary_10_3390_nu16050708
crossref_primary_10_1016_j_biopha_2023_114783
crossref_primary_10_3389_fimmu_2024_1390907
crossref_primary_10_1002_ptr_8021
crossref_primary_10_3390_ijms21113838
crossref_primary_10_1016_j_freeradbiomed_2021_05_036
crossref_primary_10_3390_antiox10020224
crossref_primary_10_1016_j_freeradbiomed_2020_11_021
crossref_primary_10_1016_j_biopha_2021_112442
crossref_primary_10_3390_molecules26164729
crossref_primary_10_1155_2021_3149223
crossref_primary_10_3390_ijms22041642
crossref_primary_10_1155_2020_6381380
crossref_primary_10_3390_ijms21103446
crossref_primary_10_1002_biof_1958
crossref_primary_10_1515_bmc_2021_0023
crossref_primary_10_3390_nu15204486
crossref_primary_10_3390_molecules26020453
crossref_primary_10_3389_fphar_2022_924473
crossref_primary_10_1042_CS20200356
crossref_primary_10_1155_2020_2604967
crossref_primary_10_1002_jcp_31071
crossref_primary_10_1080_09513590_2023_2181652
crossref_primary_10_3390_antiox12010080
crossref_primary_10_1186_s13018_020_01684_9
crossref_primary_10_1080_14786419_2022_2130304
crossref_primary_10_1155_2019_4598167
crossref_primary_10_2174_1570159X20666221012122855
crossref_primary_10_3390_ijms21144962
crossref_primary_10_3390_pharmaceutics16040569
crossref_primary_10_3390_molecules25225343
crossref_primary_10_2174_0929867329666220729153654
crossref_primary_10_1038_s41598_020_72497_3
crossref_primary_10_1016_j_jep_2022_115722
crossref_primary_10_1540_jsmr_58_89
crossref_primary_10_3390_biomedicines9080918
crossref_primary_10_3389_fphar_2022_994025
crossref_primary_10_3390_app14041422
crossref_primary_10_3390_jcm9030718
crossref_primary_10_1186_s13287_020_02069_9
crossref_primary_10_3390_antiox12020341
crossref_primary_10_3390_molecules26102834
crossref_primary_10_1007_s10495_022_01745_w
crossref_primary_10_3390_molecules27134240
crossref_primary_10_2174_1568026623666221014152759
crossref_primary_10_3389_fcell_2022_894305
crossref_primary_10_3390_ijms231911165
crossref_primary_10_1016_j_ymthe_2024_01_037
crossref_primary_10_1007_s12013_024_01233_9
crossref_primary_10_3390_ijms21062084
crossref_primary_10_3390_molecules27020424
crossref_primary_10_1021_acs_jafc_1c03699
Cites_doi 10.2203/dose-response.09-015.Mukherjee
10.1016/j.bbrc.2014.12.012
10.1093/toxsci/kfp301
10.1016/S0022-2275(20)39128-8
10.1111/j.1365-313X.2007.03280.x
10.1251/bpo20
10.2174/1573403X14666180702152436
10.1074/jbc.M116.727008
10.1089/ars.2009.2876
10.1074/jbc.273.8.4516
10.1093/cvr/cvp031
10.1016/j.cub.2014.03.034
10.1101/cshperspect.a014217
10.1124/mol.60.1.174
10.1089/ars.2010.3614
10.1021/tx300069r
10.3390/nu10091160
10.1097/01.ASN.0000077407.90309.65
10.1038/sj.onc.1208853
10.1016/j.ejphar.2018.11.016
10.1161/HYPERTENSIONAHA.107.107672
10.1111/jcmm.13088
10.2337/db16-1585
10.3389/fphar.2015.00128
10.2741/309
10.1038/s41419-018-0498-9
10.1038/s41698-017-0014-1
10.3390/molecules23092105
10.1186/s13023-014-0123-7
10.1016/j.niox.2011.12.006
10.1016/j.phymed.2018.12.024
10.1101/gad.1024602
10.1038/nrc2231
10.1016/S1065-6995(02)90926-1
10.1016/j.jnutbio.2011.06.003
10.3390/molecules191016724
10.1016/j.foodres.2011.12.019
10.1111/j.1523-1755.2004.00491.x
10.1016/j.numecd.2016.03.003
10.3390/nu10111813
10.1016/j.tiv.2017.05.005
10.1101/pdb.prot4429
10.1016/S0014-5793(98)00073-8
10.1007/s12012-013-9205-3
10.1158/1535-7163.MCT-07-0302
10.1126/science.296.5573.1655
10.1016/j.freeradbiomed.2009.03.013
10.1016/S0014-5793(99)00438-X
10.1016/S0006-2952(01)00788-2
10.18632/oncotarget.17128
10.1016/j.amjcard.2008.02.012
10.1016/S0898-6568(98)00037-0
10.1097/00000542-200403000-00008
10.1093/jn/138.9.1602
10.1002/jnr.23453
10.1016/j.yexcr.2018.06.031
10.1155/2018/2639081
10.3390/ijms130910697
10.14814/phy2.12192
10.1016/S0008-6363(03)00526-1
10.3892/etm.2017.5038
10.1158/1541-7786.MCR-06-0096
10.3892/ijo.23.2.477
10.1111/j.1399-3054.2009.01334.x
10.1016/S1097-2765(02)00520-8
10.1179/135100009X466131
10.1038/nrd2060
10.3390/biomedicines6030091
10.1371/journal.ppat.1004506
10.1111/dom.12120
10.1016/j.cellsig.2012.01.008
10.1007/PL00000852
10.1105/tpc.105.033589
10.1097/01.hjh.0000198029.22472.d9
10.1038/sj.cdd.4400770
10.1101/gad.13.15.1899
10.1016/j.fct.2013.07.021
10.1186/1476-9255-10-12
10.1016/j.jnutbio.2015.06.006
10.1007/s10495-005-2947-z
10.1155/2017/4157213
10.1016/j.bbrc.2015.01.034
10.1155/2017/9584819
10.1096/fj.06-7491com
10.1007/s00204-013-1034-4
10.1016/S0003-9861(02)00218-7
10.1371/journal.pone.0048817
10.15171/bi.2015.01
10.1016/j.fct.2015.01.017
10.3390/md13106226
10.1161/01.RES.87.10.840
10.1089/ars.2008.2412
10.1074/jbc.M007154200
10.1016/j.jnutbio.2018.02.007
10.1074/jbc.M312847200
10.1523/JNEUROSCI.22-03-00674.2002
10.1155/2016/4139851
10.1007/BF01952111
10.4196/kjpp.2017.21.4.377
10.1016/j.jnutbio.2015.05.009
10.1089/ars.2009.2825
10.1111/j.1365-4632.2004.02222.x
10.1016/j.bcp.2010.07.034
10.2174/1874091X01307010044
10.1124/pr.110.002980
10.1016/j.canlet.2018.06.012
10.1186/s12935-016-0288-3
10.1016/j.metabol.2013.04.010
ContentType Journal Article
Copyright 2019 by the authors. 2019
Copyright_xml – notice: 2019 by the authors. 2019
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3390/biom9060209
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2218-273X
ExternalDocumentID oai_doaj_org_article_a90bc745a6374b1eb5d6b65d1536d63d
10_3390_biom9060209
31151226
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 3V.
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AADQD
AAFWJ
ABDBF
ABUWG
ADBBV
AFKRA
AFPKN
AFZYC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CGR
CUY
CVF
EBD
ECM
EIF
ESX
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
IAO
KQ8
LK8
M1P
M48
M7P
MODMG
M~E
NPM
OK1
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RPM
UKHRP
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c513t-843d37c549208c346ff1aeffb10d1f136a5eb40f9510a3c0bc2a787e21c72bae3
IEDL.DBID RPM
ISSN 2218-273X
IngestDate Tue Oct 22 15:13:42 EDT 2024
Tue Sep 17 20:58:42 EDT 2024
Fri Aug 16 01:30:54 EDT 2024
Fri Aug 23 00:36:32 EDT 2024
Sat Sep 28 08:32:16 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords endothelial cells
cell damage
dose-dependence
flavin oxidase
ROS
PKC
anti- and pro-oxidant effect
resveratrol
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c513t-843d37c549208c346ff1aeffb10d1f136a5eb40f9510a3c0bc2a787e21c72bae3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ORCID 0000-0001-9252-1038
0000-0003-3524-7962
0000-0003-3460-1413
0000-0002-3031-7733
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628153/
PMID 31151226
PQID 2233857070
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_a90bc745a6374b1eb5d6b65d1536d63d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6628153
proquest_miscellaneous_2233857070
crossref_primary_10_3390_biom9060209
pubmed_primary_31151226
PublicationCentury 2000
PublicationDate 20190530
PublicationDateYYYYMMDD 2019-05-30
PublicationDate_xml – month: 5
  year: 2019
  text: 20190530
  day: 30
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Biomolecules (Basel, Switzerland)
PublicationTitleAlternate Biomolecules
PublicationYear 2019
Publisher MDPI
MDPI AG
Publisher_xml – name: MDPI
– name: MDPI AG
References ref57
ref56
ref59
ref58
ref53
ref52
ref55
ref54
ref51
ref50
ref46
ref45
ref48
ref42
ref41
ref44
ref43
ref49
ref8
ref7
ref9
ref4
ref3
ref6
ref5
Chen (ref109) 2011; 89
ref100
ref101
ref40
ref35
ref34
Moshier (ref18) 1995; 55
ref36
Pozarowski (ref69) 2004
ref31
ref30
ref33
ref32
ref39
ref38
Hibshoosh (ref26) 1991; 6
ref24
ref23
ref25
ref20
ref22
ref21
Turrens (ref2) 2013
ref28
ref27
ref13
ref12
ref15
ref14
ref97
Sisein (ref37) 2014; 2
ref96
ref11
ref99
ref10
ref98
Kontush (ref88) 1996; 37
ref17
ref16
ref19
Daksis (ref78) 1994; 9
ref93
ref92
ref95
ref94
ref91
ref90
ref89
ref86
ref85
Gao (ref29) 2017; 8
ref87
ref82
ref81
ref84
ref83
ref80
ref79
ref108
ref106
ref107
ref75
ref104
ref74
ref105
ref77
ref102
ref76
ref103
ref1
ref71
ref111
ref70
ref112
ref73
ref72
ref110
ref68
ref67
ref64
ref115
ref63
ref116
ref66
ref113
ref65
ref114
Heo (ref47) 2018; 42
ref60
ref62
ref61
References_xml – ident: ref89
  doi: 10.2203/dose-response.09-015.Mukherjee
– ident: ref30
  doi: 10.1016/j.bbrc.2014.12.012
– ident: ref43
  doi: 10.1093/toxsci/kfp301
– volume: 37
  start-page: 1436
  year: 1996
  ident: ref88
  article-title: Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein
  publication-title: J. Lipid Res.
  doi: 10.1016/S0022-2275(20)39128-8
  contributor:
    fullname: Kontush
– ident: ref57
  doi: 10.1111/j.1365-313X.2007.03280.x
– ident: ref71
  doi: 10.1251/bpo20
– ident: ref9
  doi: 10.2174/1573403X14666180702152436
– ident: ref73
  doi: 10.1074/jbc.M116.727008
– ident: ref83
  doi: 10.1089/ars.2009.2876
– ident: ref15
  doi: 10.1074/jbc.273.8.4516
– ident: ref36
  doi: 10.1093/cvr/cvp031
– volume: 55
  start-page: 5358
  year: 1995
  ident: ref18
  article-title: Ornithine decarboxylase transformation of nih/3t3 cells is mediated by altered epidermal growth factor receptor activity
  publication-title: Cancer Res.
  contributor:
    fullname: Moshier
– ident: ref3
  doi: 10.1016/j.cub.2014.03.034
– ident: ref21
  doi: 10.1101/cshperspect.a014217
– ident: ref92
  doi: 10.1124/mol.60.1.174
– volume: 6
  start-page: 739
  year: 1991
  ident: ref26
  article-title: Effects of overexpression of ornithine decarboxylase (odc) on growth control and oncogene-induced cell transformation
  publication-title: Oncogene
  contributor:
    fullname: Hibshoosh
– ident: ref34
  doi: 10.1089/ars.2010.3614
– ident: ref8
  doi: 10.1021/tx300069r
– ident: ref112
  doi: 10.3390/nu10091160
– ident: ref97
  doi: 10.1097/01.ASN.0000077407.90309.65
– ident: ref77
  doi: 10.1038/sj.onc.1208853
– ident: ref85
  doi: 10.1016/j.ejphar.2018.11.016
– volume: 89
  start-page: 793
  year: 2011
  ident: ref109
  article-title: Resveratrol inhibits cell differentiation in 3t3-l1 adipocytes via activation of ampk
  publication-title: Can. J. Physiol. Pharmacol.
  contributor:
    fullname: Chen
– ident: ref105
  doi: 10.1161/HYPERTENSIONAHA.107.107672
– ident: ref50
  doi: 10.1111/jcmm.13088
– ident: ref31
  doi: 10.2337/db16-1585
– ident: ref27
  doi: 10.3389/fphar.2015.00128
– ident: ref60
  doi: 10.2741/309
– ident: ref12
  doi: 10.1038/s41419-018-0498-9
– ident: ref24
  doi: 10.1038/s41698-017-0014-1
– ident: ref62
  doi: 10.3390/molecules23092105
– ident: ref55
  doi: 10.1186/s13023-014-0123-7
– volume: 42
  start-page: 1427
  year: 2018
  ident: ref47
  article-title: Resveratrol induced reactive oxygen species and endoplasmic reticulum stressmediated apoptosis, and cell cycle arrest in the a375sm malignant melanoma cell line
  publication-title: Int. J. Mol. Med.
  contributor:
    fullname: Heo
– ident: ref39
  doi: 10.1016/j.niox.2011.12.006
– ident: ref111
  doi: 10.1016/j.phymed.2018.12.024
– ident: ref25
  doi: 10.1101/gad.1024602
– ident: ref22
  doi: 10.1038/nrc2231
– ident: ref79
  doi: 10.1016/S1065-6995(02)90926-1
– ident: ref108
  doi: 10.1016/j.jnutbio.2011.06.003
– ident: ref41
  doi: 10.3390/molecules191016724
– ident: ref56
  doi: 10.1016/j.foodres.2011.12.019
– ident: ref102
  doi: 10.1111/j.1523-1755.2004.00491.x
– ident: ref44
  doi: 10.1016/j.numecd.2016.03.003
– ident: ref113
  doi: 10.3390/nu10111813
– ident: ref51
  doi: 10.1016/j.tiv.2017.05.005
– start-page: 2198
  year: 2013
  ident: ref2
  article-title: Reactive oxygen species
  contributor:
    fullname: Turrens
– ident: ref67
  doi: 10.1101/pdb.prot4429
– ident: ref54
  doi: 10.1016/S0014-5793(98)00073-8
– ident: ref63
  doi: 10.1007/s12012-013-9205-3
– ident: ref76
  doi: 10.1158/1535-7163.MCT-07-0302
– ident: ref7
  doi: 10.1126/science.296.5573.1655
– ident: ref90
  doi: 10.1016/j.freeradbiomed.2009.03.013
– ident: ref53
  doi: 10.1016/S0014-5793(99)00438-X
– ident: ref93
  doi: 10.1016/S0006-2952(01)00788-2
– volume: 8
  start-page: 51888
  year: 2017
  ident: ref29
  article-title: Reduction-oxidation pathways involved in cancer development: A systematic review of literature reviews
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.17128
  contributor:
    fullname: Gao
– ident: ref42
  doi: 10.1016/j.amjcard.2008.02.012
– ident: ref5
  doi: 10.1016/S0898-6568(98)00037-0
– start-page: 301
  year: 2004
  ident: ref69
  article-title: Analysis of cell cycle by flow cytometry
  contributor:
    fullname: Pozarowski
– ident: ref96
  doi: 10.1097/00000542-200403000-00008
– ident: ref103
  doi: 10.1093/jn/138.9.1602
– ident: ref116
  doi: 10.1002/jnr.23453
– ident: ref48
  doi: 10.1016/j.yexcr.2018.06.031
– ident: ref52
  doi: 10.1155/2018/2639081
– ident: ref17
  doi: 10.3390/ijms130910697
– ident: ref28
  doi: 10.14814/phy2.12192
– ident: ref65
  doi: 10.1016/S0008-6363(03)00526-1
– ident: ref72
  doi: 10.3892/etm.2017.5038
– volume: 9
  start-page: 3635
  year: 1994
  ident: ref78
  article-title: Myc induces cyclin d1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle
  publication-title: Oncogene
  contributor:
    fullname: Daksis
– ident: ref101
  doi: 10.1158/1541-7786.MCR-06-0096
– ident: ref64
  doi: 10.3892/ijo.23.2.477
– ident: ref61
  doi: 10.1111/j.1399-3054.2009.01334.x
– ident: ref23
  doi: 10.1016/S1097-2765(02)00520-8
– ident: ref87
  doi: 10.1179/135100009X466131
– ident: ref38
  doi: 10.1038/nrd2060
– ident: ref106
  doi: 10.3390/biomedicines6030091
– ident: ref4
  doi: 10.1371/journal.ppat.1004506
– ident: ref74
  doi: 10.1111/dom.12120
– ident: ref6
  doi: 10.1016/j.cellsig.2012.01.008
– ident: ref19
  doi: 10.1007/PL00000852
– ident: ref1
  doi: 10.1105/tpc.105.033589
– ident: ref104
  doi: 10.1097/01.hjh.0000198029.22472.d9
– ident: ref75
  doi: 10.1038/sj.cdd.4400770
– ident: ref91
  doi: 10.1101/gad.13.15.1899
– ident: ref84
  doi: 10.1016/j.fct.2013.07.021
– ident: ref99
  doi: 10.1186/1476-9255-10-12
– ident: ref114
  doi: 10.1016/j.jnutbio.2015.06.006
– ident: ref14
  doi: 10.1007/s10495-005-2947-z
– ident: ref98
  doi: 10.1155/2017/4157213
– ident: ref107
  doi: 10.1016/j.bbrc.2015.01.034
– ident: ref82
  doi: 10.1155/2017/9584819
– ident: ref86
  doi: 10.1096/fj.06-7491com
– ident: ref10
  doi: 10.1007/s00204-013-1034-4
– ident: ref66
  doi: 10.1016/S0003-9861(02)00218-7
– ident: ref59
  doi: 10.1371/journal.pone.0048817
– ident: ref68
  doi: 10.15171/bi.2015.01
– ident: ref46
  doi: 10.1016/j.fct.2015.01.017
– ident: ref32
  doi: 10.3390/md13106226
– ident: ref33
  doi: 10.1161/01.RES.87.10.840
– ident: ref40
  doi: 10.1089/ars.2008.2412
– ident: ref100
  doi: 10.1074/jbc.M007154200
– ident: ref110
  doi: 10.1016/j.jnutbio.2018.02.007
– ident: ref58
  doi: 10.1074/jbc.M312847200
– ident: ref16
  doi: 10.1523/JNEUROSCI.22-03-00674.2002
– ident: ref81
  doi: 10.1155/2016/4139851
– ident: ref20
  doi: 10.1007/BF01952111
– ident: ref35
  doi: 10.4196/kjpp.2017.21.4.377
– ident: ref115
  doi: 10.1016/j.jnutbio.2015.05.009
– ident: ref95
  doi: 10.1089/ars.2009.2825
– ident: ref13
  doi: 10.1111/j.1365-4632.2004.02222.x
– ident: ref45
  doi: 10.1016/j.bcp.2010.07.034
– ident: ref49
  doi: 10.2174/1874091X01307010044
– ident: ref94
  doi: 10.1124/pr.110.002980
– ident: ref11
  doi: 10.1016/j.canlet.2018.06.012
– volume: 2
  start-page: 110
  year: 2014
  ident: ref37
  article-title: Biochemistry of free radicals and antioxidants
  publication-title: Sch. Acad. J. Biosci.
  contributor:
    fullname: Sisein
– ident: ref70
  doi: 10.1186/s12935-016-0288-3
– ident: ref80
  doi: 10.1016/j.metabol.2013.04.010
SSID ssj0000800823
Score 2.4197543
Snippet Dietary intake of natural antioxidants is thought to impart protection against oxidative-associated cardiovascular diseases. Despite many in vivo studies and...
Background: Dietary intake of natural antioxidants is thought to impart protection against oxidative-associated cardiovascular diseases. Despite many in vivo...
BACKGROUNDDietary intake of natural antioxidants is thought to impart protection against oxidative-associated cardiovascular diseases. Despite many in vivo...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 209
SubjectTerms anti- and pro-oxidant effect
Cell Cycle - drug effects
cell damage
Cell Survival - drug effects
Dinitrocresols - metabolism
dose-dependence
endothelial cells
flavin oxidase
Human Umbilical Vein Endothelial Cells - cytology
Human Umbilical Vein Endothelial Cells - drug effects
Human Umbilical Vein Endothelial Cells - metabolism
Humans
Intracellular Space - drug effects
Intracellular Space - metabolism
Oxidation-Reduction - drug effects
Oxidoreductases - metabolism
PKC
Protein Kinase C - metabolism
Reactive Oxygen Species - metabolism
resveratrol
Resveratrol - pharmacology
ROS
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iyYv4tr6IIN6KSZOm7dFddhHFBz7AW8kTV2q7uLui_95JusquCF68tqEJ802Sb5rJNwgdJU4SVaQ8Jjo1MXcJjZXUeewYF0K6nBsVEmSvxNkDP39MH2dKffmcsFYeuDXciSyI0hlPpWAZV9Sq1AglUgMzVRjBTFh9STETTD1PeVCesPZCHoO4_sTfZi-IAHZUzG1BQan_N3r5M0tyZtvpr6DlKV_Ep-04V9GCrdfQ-mkNsfLLBz7GIYMz_BpfR02_km-DGl-_DwxsTrEvy6GtwbfXd7iVl_Yo4MvG-JpddoRvLrq4Mxg-SYAKtzrGuHH41o7efOPXpsLQvlcbf02rAk_FXVtV-G4C6wt46AZ66Pfuu2fxtKBCrFPKxnHOmWGZ9qJsJNeAhnNUWucUJYY6yoRMreLEedYlmQbDJxImtE2ozhIlLdtEi3VT222EGTeZEprnXnxHKFkk1Cijw9elyUWEjr5sXA5b3YwS4g0PRTkDRYQ63v7fTbzYdXgALlBOXaD8ywUidPiFXgmTw594yNo2k1EJ3Id5Bf-MRGirRfO7Ky8zRIF8Riibw3luLPNv6sFTEOAWIsmh853_GPwuWgIOVoSEBLKHFsevE7sPPGesDoJLfwLkEf4h
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZKuXBBlPJIKchIFbeAHTtOckCoXXVVgaCoZaXeIj_pojQp-6jaf8-Mk626VY9cEye25vPY3yTjbwjZy4JmpsplymzuUhkynhptyzQIqZQOpXQmJsj-UEcT-fUsP9sgq2KcgwHnD4Z2WE9qMms-Xv-9-QIO_xkjTgjZP-FB9YopID7VI_I4kxCiYw7fwPP_DLSozER_Pu_-M2s7UhTuf4ht3k-avLMLjZ-RpwN9pPs93ltkw7fPyfZ-C6HzxQ39QGNCZ_xSvk26caOvpi09vp462KtSrNJhvaMnx6e0V5tGUOj3zmEJLz-nP7-N6MH08lwDcrSXNaZdoCd-foWNZ11Dof1h6_DUVgMTl45809DTJSw3MGFfkMn48NfoKB3qK6Q252KRllI4UVjUaGOlBXBC4NqHYDhzPHChdO6NZAFJmBaWGZtp8G-fcVtkRnvxkmy2XetfEyqkK4yyskQtHmV0lXFnnI1v165UCdlb2bi-7GU0agg_EIr6DhQJOUD73zZB7et4oZv9rgdXqnUFIylkrpUopOHe5E4ZlTtYu5VTwiXk_Qq9GnwFf4Do1nfLeQ1USKCgf8ES8qpH87YrVB3iwEUTUqzhvDaW9Tvt9DzqcSuVldD5zv8Y_BvyBChZFfMT2C7ZXMyW_i3QnoV5F6f0P3VwBRM
  priority: 102
  providerName: Scholars Portal
Title Flavin Oxidase-Induced ROS Generation Modulates PKC Biphasic Effect of Resveratrol on Endothelial Cell Survival
URI https://www.ncbi.nlm.nih.gov/pubmed/31151226
https://search.proquest.com/docview/2233857070
https://pubmed.ncbi.nlm.nih.gov/PMC6628153
https://doaj.org/article/a90bc745a6374b1eb5d6b65d1536d63d
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb5swGLba7rLLtK37YN0iT6p2o8HYGHJsokTVprRRukq5IX-uVASifFTdv99rA1Uy7bQLBzBg-XmMH5v3fYzQeWxFJAcJCyOV6JDZmIRSqCy0lHEubMa09AGy1_zqjn1fJIsjlHS5MD5oX8nioiqXF1Vx72MrV0vV7-LE-rPpiPM4g57aP0bHQNC9KfpDK4GymDa5eBSm9H2XyD6IOAgj5xHq7GVI7MwU9gYi79f_L5H5d6zk3uAzeY1etaoRXza1e4OOTPUWnV5WMGNe_sbfsI_j9Avkp6ielOKxqPDNU6FhiArd5hzKaDy_ucWNybTDAk9r7XbuMhs8-zHCw2J1LwAw3LgZ49riudk8usLrusRQflxpl6xVAl_xyJQlvt3BVwZ4-g7dTcY_R1dhu61CqBJCt2HGqKapctZsUaYAE2uJMNZKEmliCeUiMZJF1mkvQVUkVSygW5uYqDSWwtD36KSqK_MRYcp0KrlimbPg4VIMYqKlVv7pQmc8QOddG-erxj0jh1mHQyXfQyVAQ9f-z0Wc5bU_Ua9_5S3wuRhATVKWCE5TJomRieaSJxqIwDWnOkBfO_Ry6CLuv4eoTL3b5KCAqPPxT6MAfWjQfH5Vx4YApQc4H9Tl8Aqw0ttwtyz89N93nqGXIL8GPhYh-oxOtuud-QISZyt7QOxF2kMvhuPr2bznFwrgOGVZz5P9D-pxAtQ
link.rule.ids 230,315,730,783,787,867,888,2109,2228,24330,27936,27937,31732,33757,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb5wwFLbS9NBeuqULXV0p6o0Zg41hjskoo2mTSaIsVW7Ia0PLwGiWqO2v77OBaCbqpb1iA4b3nv09-N5nhHZjK4gcJCwkKtEhs3EUSqGy0FLGubAZ09ITZI_5-JJ9uUqutlDS1cJ40r6SRa8qp72quPbcytlU9TueWP90MuQ8ziBS-_fQfYhXwtaS9O8tCMpi2lTjUUjq-66UfUA4QCOnEuoEZqLYySmsLUVesf9vMPMuW3Jt-Rk9Rl-7gTeskx-91VL21O87mo7__GRP0KMWkOK9pvkp2jLVM7SzV0EyPv2FP2FPEfXf3ndQPSrFTVHhk5-FhtUvdPt-KKPx2ck5bvSrnZnxpNZuUzCzwKeHQ7xfzK4F-AJuhJJxbfGZWdy4zvO6xND_oNKuDqyEUMBDU5b4fAUTGITAc3Q5OrgYjsN2x4ZQJRFdhhmjmqbKqb6RTIG5rY2EsVZGREc2olwkRjJiHawTVBGpYgEzhokjlcZSGPoCbVd1ZV4hTJlOJVcsc-o-XIpBHGmplb-60BkP0G5nvHzWCHPkkNA4c-dr5g7QvjPsbRenpu0P1PNvefvmczGAkaQsEZymTEZGJppLnmiwBNec6gB97Nwih-hzv1REZerVIgdwRd0WASkJ0MvGTW5v1blZgNINB9oYy2YLuIVX-G7d4PV_n_kBPRhfTI7yo8_Hh2_QQ0B5A095IG_R9nK-Mu8ASS3lex83fwAQZSB5
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb5wwELbaVKr60is96OlKUd9YDhsDj8k2q7RpklXSSFFfkM-GloXVHlHbX9-xgYiN-pRXGMAwM_gb-PwNQjux4aHIE-qHMlE-NXHkCy4z3xDKGDcZVcIRZI_ZwTn9cpFcDFp9OdK-FOWormajurx03Mr5TAY9TyyYHo0ZizPI1GCuTHAX3YOcDdmgUP_ZAaEsJu2KPAKFfWCXs-chA3hklUKtyEwUW0mFwXTkVPv_BzVvMiYHU9DkEfreD75lnvwarVdiJP_e0HW81d09Rg87YIp3W5Mn6I6un6Lt3RqK8tkf_BE7qqj7Br-NmknFr8oan_wuFcyCvu3_IbXCpydnuNWxtu7GR42yzcH0Ek8Px3ivnF9yiAncCibjxuBTvbyyxoumwmC_Xyu7HqyClMBjXVX4bA0vMkiFZ-h8sv9tfOB3nRt8mURk5WeUKJJKq_4WZhLcbkzEtTEiClVkIsJ4ogUNjYV3nMhQyJjDm0PHkUxjwTV5jrbqptYvESZUpYJJmlmVHyZ4HkdKKOnOzlXGPLTTO7CYtwIdBRQ21uXFwOUe2rPOvTaxqtpuQ7P4UXRPv-A5jCSlCWckpSLSIlFMsESBN5hiRHnoQx8aBWSh_bXCa92slwWALGJbBaShh160oXJ9qT7UPJRuBNHGWDb3QGg4pe8uFF7d-sj36P7006T4-vn48DV6AGAvd8yH8A3aWi3W-i0AqpV451LnHwVQIvk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Flavin+Oxidase-Induced+ROS+Generation+Modulates+PKC+Biphasic+Effect+of+Resveratrol+on+Endothelial+Cell+Survival&rft.jtitle=Biomolecules+%28Basel%2C+Switzerland%29&rft.au=Anna+Maria+Posadino&rft.au=Roberta+Giordo&rft.au=Annalisa+Cossu&rft.au=Gheyath+K.+Nasrallah&rft.date=2019-05-30&rft.pub=MDPI+AG&rft.eissn=2218-273X&rft.volume=9&rft.issue=6&rft.spage=209&rft_id=info:doi/10.3390%2Fbiom9060209&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_a90bc745a6374b1eb5d6b65d1536d63d
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2218-273X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2218-273X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2218-273X&client=summon